PATENT CLAIM ANALYSIS

Application Number: 16126210
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["540", "455000"]

Abstract:
Disclosed herein, inter alia, are compounds and methods of using the same for modulating the activity of mTORC1.

Claim (Index 64):
A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of  claim 57 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.16667
- Patent Class: 540.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15455727', '15614278', '16301200', '14849428', '15757238']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7053745839208171
- 35 USC 102 Novelty (BERT): 0.6514439083748329
- Combined Prediction Score: 0.6999815163662186
- Mean Citation Score: 500.237734
- Max Citation Score: 790.2497599999997
- Similarity Product: 554.2995845196723

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test